ArticleActa pharmaceutica Sinica. B2020

Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells.

Baoyuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.